Clinical trial
The Effect of Steroids Treatment for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients (SAF-NRVS): a Multicenter, Randomized, Double-blind, Placebo-parallel Controlled Trial
NCT07116811 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Steroids Treatment for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients (SAF-NRVS): a Multicenter, Randomized, Double-blind, Placebo-parallel Controlled Trial
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- September 1, 2025
- Completion date
- September 30, 2027
- Enrollment
- 364 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
facial nerve paralysis, vestibular schwannoma